NCW visits TCS Nashik: What the fact-finding committee will examine and why its report matters beyond this case
Read More Healthcare Industry News Anteris edges closer to FDA IDE approval for DurAVR PARADIGM trial after promising clinical data Find out how Anteris’s DurAVR transcatheter heart valve is advancing toward a global pivotal trial and what it means for the structural heart market. bySoujanya RaviNovember 3, 2025